The COVID-19 pandemic appears to be stalling research into rehabilitation and quality of life (QoL) for people with multiple sclerosis (MS) in many countries worldwide, a new observational study reports.

According to the study, many researchers have found it “significantly more” challenging to recruit participants for studies, and most investigators — across 18 countries — reported limited access to funding and research.

Read the full article at